Hiya D Asrani, MD
Pediatric Medicine · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 29 years
- Graduated 1997
Offices
1 location · Bay Area Community Health · 106 clinicians in this group
Looking this up.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Asrani’s office at (510) 770-8040 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A104653 · Current
Licensed to practise in California · since 2008 · expires 2028-01-31 · University of Mumbai, Grant Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Pediatrics - Pediatrics
Medicaid work
$1,101,493 in 2024
Medicaid paid $1,101,493 for 10,454 billed services this clinician did in 2024, up to 238 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 2,167 | $1,093,877 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 12 | $2,408 |
| Short return visit (20+ min) | 1,802 | $2,302 |
| Return visit (30+ min) | 1,512 | $1,906 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 24 | $556 |
| Short return visit | 134 | $232 |
| Long return visit (40+ min) | 52 | $81 |
| Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, amplified probe technique | 19 | $81 |
| Application of topical fluoride | 13 | $36 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 81 | $12 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 65 | $1 |
| Pain severity quantified; pain present (COA) (ONC) | 65 | $0 |
| 2024 | 10,454 | 18 | 238 | $1,101,493 |
| 2023 | 769 | 11 | 59 | $87,028 |
| 2022 | 1,904 | 17 | 61 | $141,623 |
| 2021 | 2,778 | 14 | 81 | $353,390 |
| 2020 | 2,137 | 13 | 140 | $212,889 |
| 2019 | 1,999 | 8 | 120 | $240,591 |
| 2018 | 992 | 6 | 76 | $69,472 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 154 | $78,060 |
| Short return visit (20+ min) | 295 | $5,056 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 29 | $1,494 |
| Short return visit | 84 | $922 |
| Screening test, pure tone, air only | 68 | $875 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 21 | $277 |
| Return visit (30+ min) | 20 | $206 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 20 | $112 |
| Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes | 25 | $26 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 27 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 26 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 216 | $105,804 |
| Short return visit (20+ min) | 713 | $15,380 |
| Short return visit | 201 | $4,459 |
| Screening test, pure tone, air only | 228 | $3,132 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 63 | $3,036 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 143 | $2,047 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 31 | $1,881 |
| Return visit (30+ min) | 32 | $1,788 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 25 | $1,461 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 31 | $872 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; early childhood (age 1 through 4 years) | 12 | $598 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 101 | $564 |
2021
| Clinic visit/encounter, all-inclusive | 665 | $316,129 |
| Short return visit (20+ min) | 869 | $12,928 |
| Return visit (30+ min) | 187 | $8,699 |
| Screening test, pure tone, air only | 249 | $3,443 |
| Short return visit | 472 | $3,112 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 51 | $2,545 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 42 | $2,302 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 157 | $1,682 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; late childhood (age 5 through 11 years) | 17 | $1,165 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 13 | $894 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 16 | $155 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 15 | $145 |
2020
| Clinic visit/encounter, all-inclusive | 588 | $195,368 |
| Short return visit (20+ min) | 780 | $8,627 |
| Return visit (30+ min) | 179 | $2,802 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 154 | $2,145 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 24 | $1,315 |
| Short return visit | 200 | $915 |
| Screening test, pure tone, air only | 44 | $568 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 12 | $561 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 19 | $369 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 42 | $182 |
| MEASURE BLOOD OXYGEN LEVEL | 69 | $36 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 12 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 649 | $217,293 |
| Short return visit (20+ min) | 803 | $11,185 |
| Return visit (30+ min) | 298 | $7,174 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 123 | $3,211 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 12 | $801 |
| Screening test, pure tone, air only | 54 | $571 |
| Short return visit | 13 | $339 |
| MEASURE BLOOD OXYGEN LEVEL | 47 | $18 |
2018
| Clinic visit/encounter, all-inclusive | 92 | $28,971 |
| Return visit (30+ min) | 268 | $19,436 |
| Short return visit (20+ min) | 337 | $14,973 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 143 | $3,215 |
| Screening test, pure tone, air only | 127 | $1,502 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 25 | $1,376 |
Money from drug and device companies
$118 in 2025
A payment is not proof that care is biased.
| Pfizer | Prevnar 20 | $62 | 2 payments
|
| GlaxoSmithKline | Shingrix | $23 | 1 payment
|
| Novo Nordisk | None | $17 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $16 | 1 payment
|
See all 5 published payments
| Pfizer | Meals · 2025-11-10 | Prevnar 20 | $29 |
| GlaxoSmithKline | Meals · 2025-07-31 | Shingrix | $23 |
| Novo Nordisk | Meals · 2025-07-28 | None | $17 |
| Exact Sciences | Meals · 2025-04-14 | Cologuard Collection Kit | $16 |
| Pfizer | Meals · 2025-02-24 | Prevnar 20 | $33 |
Professional record
- NPI
- 1609063718
- Licence
- CA A104653California A104653: Current · expires 2028-01-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 40910 Fremont Blvd, Fremont, CA, 94538
- NPI first listed
- 2007-10-02
- NPI last updated
- 2026-09-14
- NPI record certified
- 2026-09-14
This is when the NPI record was last certified, not a medical board exam.